DYADIC INTERNATIONAL INC Increase Decrease In Operating Lease Liability
DYADIC INTERNATIONAL INC (DYAI) reported Increase Decrease In Operating Lease Liability of -$883 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-12
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$441.00, a 7450.00% decline year-over-year.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$442.00, a 8940.00% decline year-over-year.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$440.00, a 7433.33% decline year-over-year.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$144.00, a 149.15% decline year-over-year.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for fiscal 2025 was -$573.00, a 149.02% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for fiscal 2024 was $1.17K.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for fiscal 2023 was -$4.51K.
- DYADIC INTERNATIONAL INC increase decrease in operating lease liability for fiscal 2022 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$441.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$883.00 10-Q · filed 2026-08-12 | -$1.32K derived: sum of 3 quarters · filed 2026-08-12 | -$1.47K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$442.00 10-Q · filed 2026-05-13 | -$882.00 derived: sum of 2 quarters · filed 2026-05-13 | -$1.03K derived: sum of 3 quarters · filed 2026-05-13 | -$1.02K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$440.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$584.00 derived: sum of 2 quarters · filed 2026-03-25 | -$578.00 derived: sum of 3 quarters · filed 2026-08-12 | -$573.00 10-K · filed 2026-03-25 |
| 2025-09-30 | -$144.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$138.00 derived: sum of 2 quarters · filed 2026-08-12 | -$133.00 10-Q · filed 2025-11-12 | -$127.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $6.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.00 10-Q · filed 2026-08-12 | $17.00 derived: sum of 3 quarters · filed 2026-08-12 | $310.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $5.00 10-Q · filed 2026-05-13 | $11.00 derived: sum of 2 quarters · filed 2026-05-13 | $304.00 derived: sum of 3 quarters · filed 2026-05-13 | $738.00 derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $6.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $299.00 derived: sum of 2 quarters · filed 2026-03-25 | $733.00 derived: sum of 3 quarters · filed 2026-03-25 | $1.17K 10-K · filed 2026-03-25 |
| 2024-09-30 | $293.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $727.00 derived: sum of 2 quarters · filed 2025-11-12 | $1.16K 10-Q · filed 2025-11-12 | $1.60K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $434.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $870.00 10-Q · filed 2025-08-13 | $1.31K derived: sum of 3 quarters · filed 2025-08-13 | -$3.64K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $436.00 10-Q · filed 2025-05-14 | $872.00 derived: sum of 2 quarters · filed 2025-05-14 | -$4.07K derived: sum of 3 quarters · filed 2025-05-14 | -$4.07K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $436.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$4.51K derived: sum of 2 quarters · filed 2025-03-26 | -$4.51K derived: sum of 3 quarters · filed 2025-03-26 | -$4.51K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$4.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.95K derived: sum of 2 quarters · filed 2024-11-12 | -$4.95K 10-Q · filed 2024-11-12 | -$4.95K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |